Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 8:1158:338390.
doi: 10.1016/j.aca.2021.338390. Epub 2021 Mar 19.

Combined recombinase polymerase amplification/rkDNA-graphene oxide probing system for detection of SARS-CoV-2

Affiliations

Combined recombinase polymerase amplification/rkDNA-graphene oxide probing system for detection of SARS-CoV-2

Moon Hyeok Choi et al. Anal Chim Acta. .

Abstract

The development of rapid, highly sensitive, and selective methods for the diagnosis of infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) should help to prevent the spread of this pandemic virus. In this study, we combined recombinase polymerase amplification (RPA), as a means of isothermal DNA amplification, with an rkDNA-graphene oxide (GO) probe system to allow the rapid detection of SARS-CoV-2 with high sensitivity and selectivity. We used in situ enzymatic synthesis to prepare an rkDNA probe that was complementary to an RPA-amplified sequence of the target N-gene of SARS-CoV-2. The fluorescence of this rkDNA was perfectly quenched in the presence of GO. When the quenched rkDNA-GO system was added to the RPA-amplified sequence of the target SARS-CoV-2, the fluorescence recovered dramatically. The combined RPA/rkDNA-GO system exhibited extremely high selectivity (discrimination factor: 17.2) and sensitivity (LOD = 6.0 aM) for the detection of SARS-CoV-2. The total processing time was only 1.6 h. This combined RPA/rkDNA-GO system appears to be a very efficient and simple method for the point-of-care detection of SARS-CoV-2.

Keywords: Enzymatic in situ synthetic probe (rkDNA); Fluorescence; Graphene oxide; Isothermal amplification; RPA; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Image 1
Graphical abstract
Scheme 1
Scheme 1
Combining RPA with an rkDNA–GO system for the detection of COVID-19.
Fig. 1
Fig. 1
(a) Denaturing PAGE (polyacrylamide gel electrophoresis in Urea) of the RPA for 1 nM of N-SARS-CoV-2 and N-SARS-CoV with RPA-Rev Primer and RPA-Fow Primer: lane 1: 1 nM of N-SARS-CoV-2 + RPA-Rev Primer + RPA-Fow Primer; lane 2: 1 nM of N-SARS-CoV-2 + RPA-Rev Primer + RPA-Fow Primer + RPA enzyme kit; lane 3: 1 nM of N-SARS-CoV + RPA-Rev Primer + RPA-Fow Primer; lane 4: N-SARS-CoV + RPA-Rev Primer + RPA-Fow Primer + RPA enzyme kit. (b) Non-denaturing PAGE confirming the cleavage of the extended reverse primer by Lambda exonuclease obtained through RPA lane 1: product of RPA reaction with N-SARS-CoV-2; lane 2: product of RPA reaction with N-SARS-CoV2, treated with Lambda exonuclease. The gels were stained using SYBr gold. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
Fig. 2
Fig. 2
Sensitivity of combined RPA/rkDNA–GO probing system for the detection of N-SARS-CoV-2. (a) Fluorescence response (λem = 545 nm) with error bar of the RPA/rkDNA–GO probing system in the presence of N-SARS-CoV-2 (1 fM–1 nM). (b) Linear relationship between the fluorescence response and the logarithm of the concentration of the target N-SARS-CoV-2 (from 1 fM to 1 nM). F is fluorescence response of different concentration target and Fo is fluorescence intensity of rkDNA-GO. Each sample contained 0.1 μM (1 mL) of rkDNA in 25 mM Trizma buffer (25 mM Tris, 50 mM NaCl, 10 mM MgCl2) and 0.18 mg of GO at pH 7.2. Excitation wavelength: 410 nm.
Fig. 3
Fig. 3
Selectivity of the combined RPA/rkDNA–GO probing system for 1 nM N-SARS-CoV-2 over 1 nM N-SARS-CoV, determined by their fluorescence responses at λem = 545 nm. Each sample contained 0.1 μM (1 mL) of the rkDNA in 25 mM Trizma buffer (25 mM Tris, 50 mM NaCl, 10 mM MgCl2) and 0.18 mg of GO at pH 7.2. Excitation wavelength: 410 nm.
Fig. 4
Fig. 4
Sensitivity of the combined RPA/rkDNA–GO probing system for the detection of N-SARS-CoV-2 when performing the RPA reaction for 1 h. (a) Concept for RPA amplifying by time. (b) Selectivity of the RPA/rkDNA–GO probing system for 1 fM N-SARS-CoV-2 and 1 fM N-SARS-CoV when using an RPA reaction time of 1 h, determined by the fluorescence response at λem = 545 nm. (c) Fluorescence response (λem = 545 nm) with error bar of the RPA/rkDNA–GO probing system in the presence of N-SARS-CoV-2 (1 aM–10 fM). (d) Linear relationship between the fluorescence response and the logarithm of the concentration of the target N-SARS-CoV-2 (from 1 aM to 10 fM). F is fluorescence response of different concentration target and Fo is fluorescence intensity of rkDNA-GO. Each sample contained 0.1 μM (1 mL) of rkDNA in 25 mM Trizma buffer (25 mM Tris, 50 mM NaCl, 10 mM MgCl2) and 0.18 mg of GO at pH 7.2. Excitation wavelength: 410 nm.
Fig. 5
Fig. 5
Results of spiked specimens using RPA/rkDNA-GO probing system. Blank is rkDNA-GO without target. Significantly increased fluorescence intensity in positive samples were observed.

Similar articles

Cited by

References

    1. Zhu Na, Zhang Dingyu, Wang Wenling, Li Xingwang, Yang Bo, Song Jingdong, Xiao Xiang, Huang Baoying, Shi Weifeng, Niu Roujian, Niu Peihua, Zhan Faxian, Ma Xuejun, Wang Dayan, Xu Wenbo, Wu Guizhen, Gao George F., Tan Wenjie. A novel coronavirus from patients with pneumonia in China. N. Engl. J. Med. 2019;382(2020):727–733. - PMC - PubMed
    1. Zhou Peng, Yang Xing-Lou, Wang Xian-Guang, Hu Ben, Zhang Lei, Zhang Wei, Hao-Rui Si, Zhu Yan, Li Bei, Huang Chao-Lin, Chen Hui-Dong, Chen Jing, Luo Yun, Guo Hua, Jiang Ren-Di, Liu Mei-Qin, Chen Ying, Shen Xu-Rui, Wang Xi, Zheng Xiao-Shuang, Zhao Kai, Chen Quan-Jiao, Deng Fei, Liu Lin-Lin, Yan Bing, Zhan Fa-Xian, Wang Yan-Yi, Xiao Geng-Fu, Shi Zheng-Li. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. - PMC - PubMed
    1. Shereen Muhammad Adnan, Khan Suliman, Kazmi Abeer, Bashir Nadia, Siddique Rabeea. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;24:91–98. - PMC - PubMed
    1. Corman Victor M., Rasche Andrea, Baronti Cecile, Aldabbagh Souhaib, Cadar Daniel, Chantal B., Reusken E.M., Pas Suzan D., Abraham Goorhuis, Schinkel Janke, Molenkamp Richard, Kümmerer Beate M., Tobias Bleicker, Brünink Sebastian, Eschbach-Bludau Monika, Anna M., Eis-Hübinger, Koopmans Marion P., Schmidt-Chanasit Jonas, Grobusch Martin P., de Lamballerie Xavier, Drosten Christian, Drexler Jan Felix. Assay optimization for molecular detection of Zika virus. Bull. World Health Organ. 2016;94(12):880–892. - PMC - PubMed
    1. Cao Lei, Cui Xingye, Hu Jie, Li Zedong, Choi Jane Ru, Yang Qingzhen, Lin Min, Li Ying Hui, Xu Feng. Advances in digital polymerase chain reaction (dPCR) and its emerging biomedical applications. Biosens. Bioelectron. 2017;90:459–474. - PubMed